Govt wants to ease compliance burden on Pharma Industry

The IDMA is commemorating 60 years of its establishment this year.

331
Govt of India
Govt of India

Last Updated on January 9, 2024 by The Health Master

Union Chemicals and Fertilizers Minister Mansukh Mandaviya said the government wants to reduce the compliance burden on the pharma industry for the ease of doing business.

Addressing an event of the Indian Drug Manufacturers’ Association (IDMA) here, Mandivya, who is also the Minister for Health and Family Welfare, said that the Narendra Modi-led government at the Centre is not only pro-poor and pro-farmer but “industry-friendly” as well.

The IDMA is commemorating 60 years of its establishment this year.

“We want the ease of doing business for the industry and lessen the compliance burden on it. This is why we always carry out consultations with all stakeholders prior to the formulation of any policy or regulation (governing the pharma industry),” Mandaviya said.

“Our Government is pro-poor, pro-farmer and industry-friendly government. It is dedicated to the poor and farmers but at the same time it is an industry-friendly government as well,” he emphasized.

Stating that the industry plays an important role in nation-building and also in achieving self-reliance, the minister said that today the Indian pharma industry is known in the world which is due to the efforts of both the government and the industry.

He said that the government is working to make the pharma industry self-reliant and the introduction of the Rs 15,000 crore Productivity-Linked Incentive (PLI) scheme is a step in this direction.Manufacturing of 35 Active Pharma Ingredients (API), which used to be imported earlier, has started in the country now under the PLI Scheme for the pharmaceutical sector, Mandaviya said.

NPPA fixes retail price of 23 formulations: April 2022

FDA warns websites illegally selling Amphetamine and Dextroamphetamine

16 Pharma units get ‘stop production orders’ for norm violations

Changes in Pharma Licensing: A tour

USFDA gives approval to Aleor for Lidocaine & Prilocaine cream

DCGI approves Glenmark’s phase-I clinical trial for its novel molecule GRC 54276

Moderna recalls thousands of C-19 vaccine doses

USFDA gives Zero Observations to SMS Lifesciences

NPPA fixes ceiling price of these two vaccines

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news